In today's edition of the Motley Fool's health-care show Market Checkup, analysts Max Macaluso and David Williamson discuss Stryker's surprise buyout of robotic surgical specialist MAKO Surgical, as well as other market movers in the biotech space.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Today's health-care headlines.
Alison Southwick owns shares of MAKO Surgical. David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool recommends BioMarin Pharmaceutical, Illumina, Johnson & Johnson, MAKO Surgical, and Pacific Biosciences of California. The Motley Fool owns shares of Johnson & Johnson and Zimmer Holdings. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Related Articles
This Ultra-High-Yield Dividend Stock's Recovery Plans Face Another Setback
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
Why Eli Lilly Stock Jumped by 4% Today
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
Vertex Pharmaceuticals Shines in the First Quarter
650%
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.